CA2165435A1 - Nouveaux precurseurs d'antigenes pour le rejet des tumeurs et molecules d'acides nucleiques codant pour ces precurseurs - Google Patents

Nouveaux precurseurs d'antigenes pour le rejet des tumeurs et molecules d'acides nucleiques codant pour ces precurseurs

Info

Publication number
CA2165435A1
CA2165435A1 CA002165435A CA2165435A CA2165435A1 CA 2165435 A1 CA2165435 A1 CA 2165435A1 CA 002165435 A CA002165435 A CA 002165435A CA 2165435 A CA2165435 A CA 2165435A CA 2165435 A1 CA2165435 A1 CA 2165435A1
Authority
CA
Canada
Prior art keywords
clone
mhc molecule
form complexes
isolated peptides
molecule hla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002165435A
Other languages
English (en)
Other versions
CA2165435C (fr
Inventor
Pierre Van Der Bruggen
Thierry Boon-Falleur
Pierre Coulie
Jean-Christophe Renauld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Original Assignee
Pierre Van Der Bruggen
Thierry Boon-Falleur
Pierre Coulie
Jean-Christophe Renauld
Ludwig Institute For Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/079,110 external-priority patent/US5571711A/en
Application filed by Pierre Van Der Bruggen, Thierry Boon-Falleur, Pierre Coulie, Jean-Christophe Renauld, Ludwig Institute For Cancer Research filed Critical Pierre Van Der Bruggen
Publication of CA2165435A1 publication Critical patent/CA2165435A1/fr
Application granted granted Critical
Publication of CA2165435C publication Critical patent/CA2165435C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002165435A 1993-06-17 1994-06-10 Nouveaux precurseurs d'antigenes pour le rejet des tumeurs et molecules d'acides nucleiques codant pour ces precurseurs Expired - Fee Related CA2165435C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/079,110 US5571711A (en) 1993-06-17 1993-06-17 Isolated nucleic acid molecules coding for BAGE tumor rejection antigen precursors
US08/079,110 1993-06-17
US08/196,630 US5683886A (en) 1993-06-17 1994-02-15 Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof
US08/196,630 1994-02-15
PCT/US1994/006534 WO1995000159A1 (fr) 1993-06-17 1994-06-10 Peptides isoles formant des complexes avec la molecule mhc du clone hla-c 10 et utilisation de ceux-ci

Publications (2)

Publication Number Publication Date
CA2165435A1 true CA2165435A1 (fr) 1994-12-18
CA2165435C CA2165435C (fr) 2006-08-01

Family

ID=36764221

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002165435A Expired - Fee Related CA2165435C (fr) 1993-06-17 1994-06-10 Nouveaux precurseurs d'antigenes pour le rejet des tumeurs et molecules d'acides nucleiques codant pour ces precurseurs

Country Status (1)

Country Link
CA (1) CA2165435C (fr)

Also Published As

Publication number Publication date
CA2165435C (fr) 2006-08-01

Similar Documents

Publication Publication Date Title
ZA944196B (en) Isolated peptides which form complexes with MHC molecule HLA-C-clone 10 and uses thereof
CA2223694A1 (fr) Molecules d'acide nucleique isolees, peptides formant des complexes avec la molecule du complexe majeur d'histocompatibilite (mhc) hla-a2 et leurs applications
CA2201161A1 (fr) Molecule isolee d'acide nucleique codant pour un precurseur d'un antigene de rejet tumoral
CA2159098A1 (fr) Molecules d'acide nucleique isolees codant pour le precurseur mage-3 de l'antigene de rejet des tumeurs, et ses utilisations
CA2167692A1 (fr) Methode pour diagnostiquer un trouble en determinant l'expression des precurseurs d'antigenes de rejet tumoral gage
CA2158446A1 (fr) Acide nucleique codant pour un precurseur d'antigene de rejet de tumeur
CA2219988A1 (fr) Variants de cd16-ii
AU4897096A (en) Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
CA2167693A1 (fr) Proteine inhibitrice de melanomes
NZ332369A (en) Isolated nucleic acid molecules which code for GAGE tumor rejection antigen, the tumor rejection antigen, and uses thereof
DE3751081T2 (de) [Leu 13] Motilin, dessen kodierende DNS-Moleküle und Verfahren zu dessen Herstellung.
CA2165435A1 (fr) Nouveaux precurseurs d'antigenes pour le rejet des tumeurs et molecules d'acides nucleiques codant pour ces precurseurs
CA2213001A1 (fr) Molecule isolee d'acide nucleique codant des peptides formant des complexes avec hla-cw*1601 de la molecule du cmh, et ses utilisations
TW372973B (en) Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
CA2250433A1 (fr) Dnase ii humaine
UA66753C2 (en) Immunostimulator and method for its production
DE69029259D1 (de) Polypeptid, dessen herstellung, und dieses polypeptid enthaltende pharmazeutische verbindungen und kosmetika

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed